← Back to Search

MI + MORE + NRT for Substance Abuse

Phase 3
Recruiting
Led By Nina Cooperman, PsyD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently on methadone
Age ≥18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through 52 weeks.
Awards & highlights

Study Summary

This trial tests strategies to help people quit drugs like opioids and tobacco, and evaluates if they work.

Who is the study for?
This trial is for English-speaking adults over 18 who smoke cigarettes and are currently on methadone. It's not suitable for those unable to attend sessions, pregnant or breastfeeding individuals, people with severe cognitive issues or psychosis, high suicidal risk, previous mindfulness training, or those already in smoking cessation programs.Check my eligibility
What is being tested?
The study tests the effectiveness of combining Motivational Interviewing (MI) and Mindfulness-Oriented Recovery Enhancement (MORE) with Nicotine Replacement Therapy (NRT) to reduce opioid, tobacco, and other drug use. Participants will be grouped into different combinations of support groups, MI, MORE, and NRT.See study design
What are the potential side effects?
While specific side effects aren't detailed here as it focuses on behavioral therapies combined with NRT which typically includes nicotine gum or patches that may cause mouth soreness or skin irritation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently taking methadone.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through 52 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 52 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Days of Drug Use
Days of Tobacco Use

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: MORE and No MIExperimental Treatment1 Intervention
Group II: MORE and MIExperimental Treatment1 Intervention
Group III: Support Group and No MIActive Control1 Intervention
Group IV: Support Group and MIActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
431 Previous Clinical Trials
64,238 Total Patients Enrolled
University of UtahOTHER
1,105 Previous Clinical Trials
1,782,375 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,492 Previous Clinical Trials
2,622,636 Total Patients Enrolled
~280 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top